Analyzing the trends and forecasting Global Lung Cancer Therapeutics Analyzing the trends and forecasting Global Lung C | Page 2

According to the report “Global Lung Cancer Therapeutics Market,” published by Market Data Forecast, the global market is projected to reach USD 7.81 billion by 2021 from USD 5.65 billion in 2016, at a CAGR of 6.7%. There are many ways that normal cells in the lungs change into cancer. Research into how cancer develops has led to therapies that target cancer in some very specific ways. To understand targeted therapies, it helps to look at how cells work and how they can change into cancer. Request Free Sample: http://www.marketdataforecast.com/market-reports/global-lung- cancer-therapeutics-market-893/request-sample Until the mid-2000’s, treatment options were mostly limited to surgery, chemotherapy and radiation. Now, people diagnosed with lung cancer often have newer, more personalized treatment options. The goal of targeted therapy is to accurately target your individual tumour, which hopefully leads to more effective treatments and less side effects. The purpose of this brochure is to help you understand targeted therapies and what they mean for you. Targeted therapies work in similar ways in all cancers but certain drugs are more effective in certain subtypes of lung cancer. The factors influencing the Global Market for Lung Cancer Therapeutics Market, either positively or negatively are presented in the DROC analysis. Increasing occurrences of lung cancer because of mounting smoking population is one of the major factors driving the growth of lung cancer therapeutics market. Additionally, introduction of superior priced drugs and new advanced radiation therapies are the major drivers fuelling the market growth. Novel and safer therapies could improve opportunities for growth of the global lung cancer therapeutics market. Though, generalization of the key drugs might hamper the growth of this market. For granular level understanding, the Lung Cancer Therapeutics Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segments. Request Discount: http://www.marketdataforecast.com/market-reports/global-lung- cancer-therapeutics-market-893/request-discount By Treatment Type 1) Chemotherapy  Cisplatin  Taxol